Channing Der Archives - UNC Lineberger (original) (raw)

Headshots of Channing Der and Adrienne Cox.NIH Director Monica Bertagnolli, MD, wrote about research led by UNC Lineberger’s Channing Der, PhD, and Adrienne Cox, PhD, that provided the most comprehensive molecular portrait of the workings of KRAS.

Jen Jen Yeh speaks at a podium at the 2024 UNC Lineberger Scientific Symposium.UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.

Cluster of pancreatic cancer cells.UNC Lineberger researchers have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene, and how its activities impact pancreatic cancer outcomes.

UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.

Photo of pancreatic cancer cellThe National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.

UNC Lineberger’s Channing Der, PhD, and Kirsten Bryant, PhD, are among seven recipients of the inaugural Pancreatic Cancer Action Network (PanCAN) Therapeutic Accelerator Collaborative Award, which provides a total of $340,000 in grant support over two years.

Channing Der kicks off the 2022 ITCMS Director's Career Symposium.UNC Lineberger hosted a symposium for postdoctoral fellows to hear from three scientists who have chosen different science career paths after earning their doctoral degree.

Jen Jen Yeh presenting research at the Scientific SymposiumUNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.

Headshots of Autumn McRee and Jen Jen YehThe Pancreatic Cancer Center of Excellence brings together researchers, clinicians and staff to provide excellent multidisciplinary patient care and generate research discoveries that can be translated into new, more effective approaches for pancreatic cancer.